172 related articles for article (PubMed ID: 8346930)
21. [Intraperitoneal chemotherapy through implantable injection port in patients with advanced ovarian (or tubal) carcinoma].
Ryuko K; Iwanari O; Moriyama M; Moriyama M; Nakayama S; Miyako J; Kitao M
Gan To Kagaku Ryoho; 1991 Aug; 18(11):2052-7. PubMed ID: 1877848
[TBL] [Abstract][Full Text] [Related]
22. [Intraperitoneal chemotherapy for gastric carcinoma combined with peritoneal dissemination by intraperitoneal catheter with a subcutaneous reservoir].
Kurita A; Takashima S; Takayama T; Doihara H
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2439-44. PubMed ID: 7944489
[TBL] [Abstract][Full Text] [Related]
23. Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer.
Malmström H; Rasmussen S; Simonsen E
Gynecol Oncol; 1993 May; 49(2):166-71. PubMed ID: 8504983
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacokinetics of CDDP by the route of administration in patients with ovarian cancer].
Takada M; Usui N; Suzuki M; Furugen Y; Yamamoto T
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Feb; 45(2):99-105. PubMed ID: 8429253
[TBL] [Abstract][Full Text] [Related]
25. [Intra-arterial infusion chemotherapy for advanced uterine cancer before surgical treatment].
Kobayashi O; Kuwae C; Yoshiki N; Kohyama A; Kitada H; Ohtsuka H
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1692-5. PubMed ID: 8373251
[TBL] [Abstract][Full Text] [Related]
26. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
Morgan RJ; Braly P; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Najera L; Johnson D; Doroshow JH
Gynecol Oncol; 2000 Jun; 77(3):433-8. PubMed ID: 10831355
[TBL] [Abstract][Full Text] [Related]
27. Combination chemotherapy with paclitaxel and intraperitoneal cisplatin for ovarian cancer with disseminated lesions in the peritoneum and the diaphragm.
Terauchi F; Moritake T; Yamamoto Y; Ogura H
Int J Clin Oncol; 2002 Dec; 7(6):356-60. PubMed ID: 12494251
[TBL] [Abstract][Full Text] [Related]
28. [Pharmacokinetic analysis of intra-peritoneal administration of cisplatin].
Terashima M; Ikeda K; Takagane A; Sasaki N; Abe K; Araya M; Nishizuka S; Yonezawa H; Irinoda T; Nakaya T; Oyama K; Saito K
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1859-62. PubMed ID: 9382551
[TBL] [Abstract][Full Text] [Related]
29. Intraperitoneal carboplatin and etoposide for persistent epithelial ovarian cancer: analysis of results by prior sensitivity to platinum-based regimens.
Muggia FM; Groshen S; Russell C; Jeffers S; Chen SC; Schlaerth J; Curtin J; Morrow CP
Gynecol Oncol; 1993 Aug; 50(2):232-8. PubMed ID: 8375739
[TBL] [Abstract][Full Text] [Related]
30. [Intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis using totally implantable peritoneal access system].
Tokushige M; Takao S; Hokita S; Maenohara S; Aikou T; Shimazu H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2743-7. PubMed ID: 2782886
[TBL] [Abstract][Full Text] [Related]
31. [A case report of an advanced ovarian cancer (stage T4) treated with a total amount of 1815 mg of CDDP].
Maruyama M; Noda T; Kiyozuka Y; Okamura Y; Ibaraki T; Katou Y; Ninomiya Y; Oku M; Nabuchi K; Hino K
Gan No Rinsho; 1987 Oct; 33(12):1507-14. PubMed ID: 3119892
[TBL] [Abstract][Full Text] [Related]
32. [Arterial infusion therapy with implantable port for inoperable hepatobiliary tumors].
Higashi S; Kato C; Sakumoto H; Sumiyoshi K; Takahahsi T; Matsumoto K; Kane T; Sakoda M; Takahashi M; Hosono Y; Asano M; Yamamoto A
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1764-7. PubMed ID: 10560390
[TBL] [Abstract][Full Text] [Related]
33. A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with Stage II-IV epithelial ovarian cancer following negative surgical assessment.
Barakat RR; Almadrones L; Venkatraman ES; Aghajanian C; Brown C; Shapiro F; Curtin JP; Spriggs D
Gynecol Oncol; 1998 Apr; 69(1):17-22. PubMed ID: 9570993
[TBL] [Abstract][Full Text] [Related]
34. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor.
Nakagawa H; Fujita T; Kubo S; Tokiyoshi K; Yamada M; Kanayama T; Hagiwara Y; Nakanomyo H; Hiraoka M
Cancer Chemother Pharmacol; 1996; 37(4):317-26. PubMed ID: 8548876
[TBL] [Abstract][Full Text] [Related]
35. Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma.
Sakuragi N; Nakajima A; Nomura E; Noro N; Yamada H; Yamamoto R; Fujimoto S
Gynecol Oncol; 2000 Dec; 79(3):420-3. PubMed ID: 11104613
[TBL] [Abstract][Full Text] [Related]
36. [A case of stage IVb ovarian carcinoma successfully treated with intra-arterial infusion chemotherapy using implantable reservoir system].
Kobayashi O; Kuwae C; Kohyama A; Yorinaga Y; Sudo H; Kitada H; Otsuka H; Minami T
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1697-700. PubMed ID: 1530335
[TBL] [Abstract][Full Text] [Related]
37. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
Tournigand C; Louvet C; Molitor JL; Dehni N; Lejeune V; Sezeur A; Pigne A; Marpeau L; Cady J; de Gramont A
Gynecol Oncol; 2001 Nov; 83(2):198-204. PubMed ID: 11606072
[TBL] [Abstract][Full Text] [Related]
38. [Intraperitoneal cancer chemotherapy using an implantable reservoir in patients with peritonitis carcinomatosa].
Tsuji Y; Nishimura A; Katsuki Y; Yasuda T; Araya E
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1800-3. PubMed ID: 1877821
[TBL] [Abstract][Full Text] [Related]
39. Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
Petignat P; du Bois A; Bruchim I; Fink D; Provencher DM
Crit Rev Oncol Hematol; 2007 May; 62(2):137-47. PubMed ID: 17188887
[TBL] [Abstract][Full Text] [Related]
40. Five-year survival after second-line cisplatin-based intraperitoneal chemotherapy for advanced ovarian cancer.
Recio FO; Piver MS; Hempling RE; Driscoll DL
Gynecol Oncol; 1998 Mar; 68(3):267-73. PubMed ID: 9570979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
